A new paper by Australian and US investigators examining glaucoma suspects has found more frequent six-monthly reviews actually cost the...
Read moreA new study has shown up to a third of neovascular age-related macular degeneration (nAMD) patients may safely be...
Read moreThe difference between the biological age of a person's retina and their actual age is linked to their risk of...
Read moreGlaukos has commenced Phase 2 trials of two investigational cream-based drug candidates that are applied to the eyelids to treat...
Read moreEye researchers from The Australian National University (ANU) have identified unique molecular signals that could hold the key to developing...
Read moreA three-month study of a bionic eye being developed by a team of biomedical researchers at the University of Sydney...
Read moreResearchers from the Centre for Eye Health (CFEH) and UNSW have published a new review demonstrating visual field testing in...
Read moreNew research evaluating the effect of eye protection on COVID-19 transmission among healthcare workers has found face shields may have...
Read moreThe Vision Eye Institute (VEI) has launched the new not-for-profit Future Vision Foundation to support ophthalmic research, as well as...
Read moreIvantis has revealed new data from its five-year HORIZON pivotal trial showing its Hydrus Microstent device lowers the rate of...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited